We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Netscientific Plc | LSE:NSCI | London | Ordinary Share | GB00BN4R5Q82 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 1.60% | 63.50 | 62.00 | 65.00 | 63.50 | 62.50 | 62.50 | 50,613 | 09:16:15 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 1M | -3.09M | -0.1312 | -4.84 | 14.97M |
From May 2019 to May 2024
TIDMNSCI
RNS Number : 0439Q
NetScientific PLC
07 September 2017
("NetScientific" or the "Company" or the "Group")
Notice of Interim Results
London, UK - 7 September 2017 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that it will report its financial results for the 6 months ended 30 June 2017 on Thursday 28 September 2017.
Francois Martelet, Chief Executive Officer, and Ian Postlethwaite, Chief Financial Officer, will hold a presentation and conference call for analysts on the day of results at 11:00 at Consilium Strategic Communications' offices, 41 Lothbury, EC2R 7HG.
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800 François R. Martelet, M.D., CEO Ian Postlethwaite, CFO Stifel Nicolaus Europe Tel: +44 (0)20 7710 7600 Limited (NOMAD and broker) Jonathan Senior/ David Arch/ Ben Maddison Consilium Strategic Tel: +44 (0)20 3709 5700 Communications netscientific@consilium-comms.com Mary-Jane Elliott / Jessica Hodgson / Chris Welsh / Laura Thornton
About NetScientific Plc
NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOROKADQFBKDBCK
(END) Dow Jones Newswires
September 07, 2017 02:01 ET (06:01 GMT)
1 Year Netscientific Chart |
1 Month Netscientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
